Reflux Testing Devices Market Size – By Product Type (Reflux Capsule, Reflux Probe, Reflux Catheter), By Application, By End-use – Global Forecast 2022-2032

Reflux Testing Devices Market Size

Reflux Testing Devices Market was valued at USD 3.2 billion in 2022 and is estimated to account for USD 5 billion by 2032 driven by the increasing prevalence of gastroesophageal reflux disease (GERD). Lifestyle changes, dietary habits, and an aging population base have contributed to the rising number of individuals experiencing GERD-related symptoms, such as heartburn and regurgitation. As awareness of the potential complications of untreated GERD grows among patients and healthcare providers, there is a heightened demand for accurate diagnostic tools and monitoring devices.
 

The growing elderly population base suffering from GERD is a major factor stimulating the demand for reflux testing devices. For instance, nearly 11 million people, or 19% of the population, are over the age of 65 today. In another ten years, this is going to grow to roughly 13 million people, or 22% of the population. Such rise in geriatric population base will increase the demand for reflux testing and monitoring. Older people are more likely to have GERD, which, if unaddressed, can cause serious consequences. In addition, due to age-related changes in the digestive tract, number of individuals are at risk for developing GERD with time that has been observed in the global elderly population. As a result, there is an increasing demand for precise diagnostic instruments and monitoring systems to evaluate the severity of GERD and direct individualized treatment regimens.

COVID-19 Impact

The COVID-19 pandemic had a negative impact on the reflux testing devices market leading to reduced demand due to lockdown, restrictions, and consumer spending constraints. Non-emergency medical operations and elective surgeries were delayed or cancelled during the peak of the epidemic in order to lower the risk of viral transmission. As a result, there was a brief decline in the demand for reflux testing equipment. COVID-19 primarily affected the respiratory system, and healthcare systems around the world directed significant resources towards respiratory disease testing. This shift in focus may have temporarily diverted attention and resources away from gastrointestinal disorders such as GERD, impacting the demand for reflux testing.
 

Reflux Testing Devices Market Trends

GERD is no longer a rare affliction; it is a widespread condition affecting a substantial portion of the population. In the U.S. alone, GERD is estimated to affect over 20% of adults regularly, with millions experiencing symptoms intermittently. Globally, GERD’s prevalence is on the rise and is one of the driving forces behind the surge in GERD diagnosis. For instance, a study published in the Journal of Gastroenterology and Hepatology found that 63% of respondents were familiar with GERD symptoms, indicating improved public awareness.
 

Furthermore, people are more informed than ever about GERD’s signs and symptoms, through an abundance of information available online and through healthcare providers. Public health campaigns, medical literature, and online resources have made it easier for individuals to recognize the signs of GERD, such as heartburn, regurgitation, and persistent coughing, leading to a proactive approach in seeking medical evaluation.
 

Reflux Testing Devices Market Analysis

The reflux testing devices market by product type is segregated into reflux capsule, reflux probe, and reflux catheter. The reflux capsule segment is predicted to witness CAGR of 5.2% by 2032. The reflux capsule market is reshaping the landscape of GERD diagnosis with their patient-friendly approach, and remarkable technological advancements. These capsules offer numerous benefits over traditional procedures such as accurate diagnoses and real-time monitoring of treatment effectiveness. As technology continues to advance, the future of GERD management appears brighter than ever, promising improved outcomes and a higher quality of life for those living with this common gastrointestinal condition.
 

The reflux testing devices market by application is categorized into gastroesophageal reflux disease, surgical procedures, and others. The gastroesophageal reflux disease segment accounted for USD 2 billion revenue size in the year 2022. Globally, there were nearly 800 million GERD cases reported in 2019 as per study conducted by the Global Burden of Disease (GBD).
 

In Western countries, GERD is particularly common, with an estimated prevalence of 20-25%. However, it is not confined to these regions, as it increasingly affects populations in Asia, the Middle East, and Africa. Its prevalence is influenced by various factors, including lifestyle choices, obesity rates, and an aging population. However, the growing awareness of GERD and the proactive approach of healthcare providers have led to higher diagnosis rate, enabling individuals to seek timely treatment and management.
 

Based on end-use, the reflux testing devices market is segmented into hospitals, diagnostic centers, ambulatory surgical centers, and others. The hospitals segment accounted for 47% market share in the year 2022. Hospitals offer a one-stop solution for patients, encompassing diagnosis, treatment, and surgical interventions. Their comprehensive patient care, specialized expertise, access to advanced technologies, and strong referral networks contribute to their market dominance. As hospitals continue to invest in research and innovation, their influence in the field of GERD diagnosis and management is expected to grow even further. Patients and healthcare providers alike benefit from the convenience, expertise, and state-of-the-art facilities that hospitals offer in the quest for accurate reflux testing and effective GERD management.
 

U.S. reflux testing devices market accounted for USD 1 billion revenue size in 2022. The widespread use of reflux testing equipment is facilitated by the developed healthcare infrastructure in the U.S. and accessibility to cutting-edge technology including surgical robots, capsule endoscopy, and others. The ageing of the population and technological development both contribute to market expansion. Furthermore, the U.S.'s dominant position in the market is further cemented by significant market competitors, well-developed marketing tactics, and governmental approvals.
 

Reflux Testing Devices Market Share

Some of the eminent market participants operating in the reflux testing devices industry include :

• Medtronic
• Biomedix
• Johnson & Johnson Services, Inc
• Diversatek, Inc.
• Laborie
• Diversatek Healthcare
• Creo Medical Group PLC
• JINSHAN Science & Technology (Group) Co., Ltd.
• Thermo Fisher Scientific
• EB Neuro S.p.A.
   

Reflux Testing Devices Industry News:

• In April 2023, Laborie introduced the alpHaONE system, which is capable of recording data for up to 96 hours and has been developed to diagnose GERD. AlpHaONE is a patient-centered solution that enables convenient monitoring and precise, accurate data. The extensive software programme included in the alpHaONE system includes a Virtual Instruction Programme that facilitates simple navigation. A seamless user experience is further ensured by user-customizable symptom buttons and automatic pH data analysis. This launch will help the company in strengthening its product portfolio.
   
• In Febuary 2023, Diversatek Healthcare, Inc., acquired Group G-Flex (GFE do Brasil), a producer and distributor of single-use and reusable endoscopy tools and devices. The acquisition significantly expanded the company’s global presence and adds a wide range of goods to its portfolio. As a result of the acquisition, Diversatek Healthcare gained access to around 250 SKUs, including goods for the gastrointestinal and pulmonary niche sectors. This acquisition strategy will boost the sales and earnings of the company.
   

Reflux testing devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD and volume in Units from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Product Type (USD Million & Units)

• Reflux capsule
• Reflux probe
• Reflux catheter

By Application (USD Million)

• Gastroesophageal reflux disease
• Surgical procedures
• Others

By End-use (USD Million)

• Hospitals
• Diagnostic centers
• Ambulatory surgical centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Switzerland
  • The Netherlands
  • Denmark
  • Poland
  • Sweden
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • New Zealand
  • Thailand
  • Vietnam
  • Indonesia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Turkey